Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.97 |
| ▸ | C9 | P02748 | 3/20 | 0.97 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.97 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.97 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.97 |
| ▸ | APEX1 | P27695 | 2/20 | 0.97 |
| ▸ | CTH | P32929 | 2/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.97 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.97 |
| ▸ | THRB | P10828 | 2/20 | 0.97 |
| ▸ | HPGD | P15428 | 2/20 | 0.97 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.97 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.97 |
| ▸ | RECQL | P46063 | 2/20 | 0.97 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aurintricarboxylic Acid SCHEMBL4644958 | 1.00 | MEN1 (0.97) | MEN1KMT2AC9CYP2C9CYP2C19 | |
| Aurintricarboxylic Acid SCHEMBL10791075 | 1.00 | MEN1 (0.97) | MEN1KMT2AC9CYP2C9CYP2C19 | |
| Aurintricarboxylic Acid SCHEMBL30831678 | 1.00 | MEN1 (0.97) | MEN1KMT2AC9CYP2C9CYP2C19 | |
| Aurintricarboxylic Acid SCHEMBL515038 | 1.00 | MEN1 (0.97) | MEN1KMT2AC9CYP2C9CYP2C19 | |
| Aurintricarboxylic Acid SCHEMBL29450069 | 0.99 | MEN1 (1.00) | MEN1KMT2AC9CYP2C9CYP2C19 | |
| Aurintricarboxylic Acid SCHEMBL29353681 | 0.99 | MEN1 (1.00) | MEN1KMT2AC9CYP2C9CYP2C19 | |
| Aurintricarboxylic Acid SCHEMBL98495 | 0.99 | MEN1 (1.00) | MEN1KMT2AC9CYP2C9CYP2C19 | |
| Aurintricarboxylic Acid SCHEMBL6158321 | 0.97 | MEN1 (0.97) | MEN1KMT2AC9CYP2C9CYP2C19 | |
| Aurintricarboxylic Acid SCHEMBL15874321 | 0.97 | MEN1 (0.97) | MEN1KMT2AC9CYP2C9CYP2C19 | |
| Aurintricarboxylic Acid SCHEMBL6847597 | 0.96 | MEN1 (0.95) | MEN1KMT2AC9CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12560066-B2 | Systems and methods of initiating energetic reactions for reservoir stimulation | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2026-02-24 | — | — | US | claimed |
| EP-4271200-B1 | A MEAT SUBSTITUTE COMPRISING AN ANIMAL MYOGLOBIN FROM MAMMOTH | PALEO B V (BE) | 2026-04-22 | — | — | EP | disclosed |
| US-12560066-B2 | Systems and methods of initiating energetic reactions for reservoir stimulation | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4596577-A2 | MEAT SUBSTITUTE COMPRISING ANIMAL MYOGLOBIN | Paleo B.V. (BE) | 2025-08-06 | — | — | EP | disclosed |
| US-20250243739-A1 | Systems and Methods of Initiating Energetic Reactions for Reservoir Stimulation | SCHLUMBERGER TECHNOLOGY CORP (US) | 2025-07-31 | — | — | US | disclosed |
| US-20250198268-A1 | METHODS OF TREATMENT OF SUBTERRANEAN FORMATION WITH POLYMERIC STRUCTURES FORMED IN SITU | SCHLUMBERGER TECHNOLOGY CORP (US) | 2025-06-19 | — | — | US | disclosed |
| US-12281559-B2 | Systems and methods of initiating energetic reactions for reservoir stimulation | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2025-04-22 | — | — | US | disclosed |
| CN-113862217-B | Method for culturing mammalian cells | 上海药明生物技术有限公司 | 2024-12-06 | — | — | CN | disclosed |
| US-20240402196-A1 | Method for Stabilizing Hemoglobin and Reagents for Performing the Same | EXACT SCIENCES CORPORATION | 2024-12-05 | — | — | US | disclosed |
| EP-4450974-A2 | METHOD FOR STABILIZING HEMOGLOBIN AND REAGENTS FOR PERFORMING THE SAME | Exact Sciences Corporation (US) | 2024-10-23 | — | — | EP | disclosed |
| WO-2022040571-A9 | ROOM TEMPERATURE STABLE, DRY BIOLOGICAL TRANSPORT MEDIA | GENTEGRA, LLC (US) | 2022-12-01 | — | — | WO | disclosed |
| US-20220373564-A1 | METHOD FOR STABILIZING HEMOGLOBIN AND REAGENTS FOR PERFORMING THE SAME | JPMORGAN CHASE BANK, N.A. | 2022-11-24 | — | — | US | disclosed |
| US-20220275028-A1 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | NATURE'S TOOLBOX, INC. | 2022-09-01 | — | — | US | disclosed |
| EP-4032900-A1 | NEW ENZYMES AND METHODS FOR VANILLIC ACID-RELATED METABOLIC PATHWAYS | Koninklijke Nederlandse Akademie van Wetenschappen (NL) | 2022-07-27 | — | — | EP | disclosed |
| US-11385243-B2 | Method for stabilizing hemoglobin and reagents for performing the same | EXACT SCIENCES CORPORATION (US) | 2022-07-12 | — | — | US | disclosed |
| WO-2022144434-A1 | MEAT SUBSTITUTE COMPRISING ANIMAL MYOGLOBIN | PALEO B.V. (BE) | 2022-07-07 | — | — | WO | disclosed |
| EP-4019627-A1 | NEW ENZYMES AND METHODS FOR BENZOIC ACID-RELATED METABOLIC PATHWAYS | Koninklijke Nederlandse Akademie van Wetenschappen (NL) | 2022-06-29 | — | — | EP | disclosed |
| WO-2022040571-A1 | ROOM TEMPERATURE STABLE, DRY BIOLOGICAL TRANSPORT MEDIA | GENTEGRA, LLC (US) | 2022-02-24 | — | — | WO | disclosed |
| EP-3953366-A1 | SYSTEMS, METHODS AND COMPOSITIONS FOR RECOMBINANT IN VITRO TRANSCRIPTION AND TRANSLATION UTILIZING THERMOPHILIC PROTEINS | Nature's Toolbox, Inc. (US) | 2022-02-16 | — | — | EP | disclosed |
| US-11247394-B2 | Additive manufacturing techniques | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2022-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220275028-A1 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | MRPL21, RNGTT, MRPS23 | MEN1 4115/4885KMT2A 2339/4885C9 3850/4885 |
| US-12560066-B2 | Systems and methods of initiating energetic reactions for reservoir stimulation | PIEZO1, TRPV4, TRPV2 | MEN1 1534/4885KMT2A 3904/4885C9 4618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.